Why Analysts See Vertex Pharmaceuticals Story Shifting With New Pipeline Momentum and Valuation Debates

Vertex Pharmaceuticals has seen its fair value estimate inch up from about $480 to roughly $485 per share as analysts refresh ...

Is Vertex Still a Bargain After Latest Pipeline Progress and Five Year 90.6% Gain?

If you have ever wondered whether Vertex Pharmaceuticals is a bargain right now, you are not alone. Let's break down whether the current price really stacks up to the company's fundamentals. Despite ...

Where Will Vertex Pharmaceuticals Be in 5 Years

A lot can change in five years. Take Vertex Pharmaceuticals ( VRTX +0.55%), for example. In late 2020, the big biotech ...
STAT

A Q&A with Vertex founder Joshua Boger on Casgevy, the biotech industry, and Elon Musk

Vertex Pharmaceuticals made history Friday when it received regulatory approval for a medicine that could alter people’s DNA. While the company celebrated, its founder, Joshua Boger, looked on like a ...
Geeky Gadgets

How to build AI apps on Vertex AI with LangChain

If you are interested in learning more about how you can utilize the power of artificial intelligence and specifically generative AI into your applications. You are sure to enjoy this quick overview ...
The Business Journals

Peaking late: How Vertex became biotech's model citizen

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The story of how Vertex went from being a potential also ...